BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 31644910)

  • 81. Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas.
    Wimberger N; Ober F; Avar G; Grau M; Xu W; Lenz G; Menden MP; Krappmann D
    Blood; 2023 Dec; 142(23):1985-2001. PubMed ID: 37623434
    [TBL] [Abstract][Full Text] [Related]  

  • 82. CARMA1 is required for Akt-mediated NF-kappaB activation in T cells.
    Narayan P; Holt B; Tosti R; Kane LP
    Mol Cell Biol; 2006 Mar; 26(6):2327-36. PubMed ID: 16508008
    [TBL] [Abstract][Full Text] [Related]  

  • 83. ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans.
    Hathcock KS; Padilla-Nash HM; Camps J; Shin DM; Triner D; Shaffer AL; Maul RW; Steinberg SM; Gearhart PJ; Staudt LM; Morse HC; Ried T; Hodes RJ
    Blood; 2015 Nov; 126(20):2291-301. PubMed ID: 26400962
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II.
    Ishiguro K; Ando T; Goto H; Xavier R
    Mol Immunol; 2007 Mar; 44(8):2095-100. PubMed ID: 17052756
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency.
    Lu HY; Sharma M; Sharma AA; Lacson A; Szpurko A; Luider J; Dharmani-Khan P; Shameli A; Bell PA; Guilcher GMT; Lewis VA; Vasquez MR; Desai S; McGonigle L; Murguia-Favela L; Wright NAM; Sergi C; Wine E; Overall CM; Suresh S; Turvey SE
    J Allergy Clin Immunol; 2021 Dec; 148(6):1559-1574.e13. PubMed ID: 33872653
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.
    Wang W; Chang X; Yao W; Wei N; Huo N; Wang Y; Wei Q; Liu H; Wang X; Zhang S; Yang Z; Xiao S
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31554683
    [TBL] [Abstract][Full Text] [Related]  

  • 88. GSK3β modulates NF-κB activation and RelB degradation through site-specific phosphorylation of BCL10.
    Abd-Ellah A; Voogdt C; Krappmann D; Möller P; Marienfeld RB
    Sci Rep; 2018 Jan; 8(1):1352. PubMed ID: 29358699
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain.
    Jattani RP; Tritapoe JM; Pomerantz JL
    J Biol Chem; 2016 Apr; 291(16):8338-48. PubMed ID: 26884334
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Targeting MALT1 for the treatment of diffuse large B-cell lymphoma.
    Seshadri MR; Melnick AM
    Leuk Lymphoma; 2022 Apr; 63(4):789-798. PubMed ID: 34783281
    [TBL] [Abstract][Full Text] [Related]  

  • 91. CD4 ligation excludes the Carma1-Bcl10-MALT1 complex from GM1-positive membrane rafts in CD3/CD28 activated T cells.
    Rigo M; Chentouf M; Pèlegrin A; Chardès T
    Cell Immunol; 2011; 270(1):40-6. PubMed ID: 21489413
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex.
    Park Y; Jin HS; Liu YC
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9433-8. PubMed ID: 23690623
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells.
    Dubois SM; Alexia C; Wu Y; Leclair HM; Leveau C; Schol E; Fest T; Tarte K; Chen ZJ; Gavard J; Bidère N
    Blood; 2014 Apr; 123(14):2199-203. PubMed ID: 24497531
    [TBL] [Abstract][Full Text] [Related]  

  • 94. BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.
    Xia M; David L; Teater M; Gutierrez J; Wang X; Meydan C; Lytle A; Slack GW; Scott DW; Morin RD; Onder O; Elenitoba-Johnson KSJ; Zamponi N; Cerchietti L; Lu T; Philippar U; Fontan L; Wu H; Melnick AM
    Cancer Discov; 2022 Aug; 12(8):1922-1941. PubMed ID: 35658124
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Transition from heterotypic to homotypic PDK1 homodimerization is essential for TCR-mediated NF-κB activation.
    Kang JA; Jeong SP; Park D; Hayden MS; Ghosh S; Park SG
    J Immunol; 2013 May; 190(9):4508-15. PubMed ID: 23530144
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The signaling relations between three adaptors of porcine C-type lectin receptor pathway.
    Jiang S; Ao D; Ni J; Chen N; Meurens F; Zhu J
    Dev Comp Immunol; 2020 Mar; 104():103555. PubMed ID: 31751629
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
    Davis RE; Ngo VN; Lenz G; Tolar P; Young RM; Romesser PB; Kohlhammer H; Lamy L; Zhao H; Yang Y; Xu W; Shaffer AL; Wright G; Xiao W; Powell J; Jiang JK; Thomas CJ; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Johnson NA; Rimsza LM; Campo E; Jaffe ES; Wilson WH; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pierce SK; Staudt LM
    Nature; 2010 Jan; 463(7277):88-92. PubMed ID: 20054396
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.
    Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
    Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Ubiquitination for activation: new directions in the NF-kappaB roadmap.
    Lynch OT; Gadina M
    Mol Interv; 2004 Jun; 4(3):144-6. PubMed ID: 15210867
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells.
    Kloo B; Nagel D; Pfeifer M; Grau M; Düwel M; Vincendeau M; Dörken B; Lenz P; Lenz G; Krappmann D
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):272-7. PubMed ID: 21173233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.